Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215,538 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression.
Feng Y, Wang J, Shao Z, Chen Z, Yao T, Dong S, Wu Y, Shi X, Shi J, Liu G, Bai J, Guo H, Liu H, Wu X, Liu L, Song X, Zhu J, Wang S, Liang X. Feng Y, et al. Among authors: wang j, wang s. Hum Vaccin Immunother. 2021 Sep 2;17(9):3214-3220. doi: 10.1080/21645515.2021.1895603. Epub 2021 May 14. Hum Vaccin Immunother. 2021. PMID: 33989106 Free PMC article. Clinical Trial.
Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China.
Yao T, Shao Z, Wu L, Dong S, Gao L, Wu Y, Shi X, Shi J, Liu G, Wang J, Zhao H, Guo H, Liu H, Wu X, Liu L, Song X, Zhu J, Zhang Y, Feng Y, Liang X, Wang S. Yao T, et al. Among authors: wang j, wang s. Vaccine. 2021 Apr 28;39(18):2537-2544. doi: 10.1016/j.vaccine.2021.03.074. Epub 2021 Apr 2. Vaccine. 2021. PMID: 33814231 Clinical Trial.
Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial.
Feng Y, Yao T, Han Y, Shi J, Dong S, Wu Y, Shao Z, Liu H, Guo H, Chai G, Liu L, Wang F, Wang J, Liang X, Wang S. Feng Y, et al. Among authors: wang f, wang j, wang s. Expert Rev Vaccines. 2021 Jun;20(6):743-751. doi: 10.1080/14760584.2021.1915777. Epub 2021 May 31. Expert Rev Vaccines. 2021. PMID: 34058948 Free article. Clinical Trial.
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China.
Han Y, Cao N, Lu X, Yao T, Shi J, Wu Y, Dong S, Shao Z, Wang J, Liu H, Guo H, Chai G, Liu L, Wang F, Feng Y, Liang X, Wang S. Han Y, et al. Among authors: wang f, wang j, wang s. Expert Rev Vaccines. 2022 Nov;21(11):1675-1682. doi: 10.1080/14760584.2022.2112951. Epub 2022 Aug 18. Expert Rev Vaccines. 2022. PMID: 35968570 Free article. Clinical Trial.
Immunogenicity, safety, and persistence induced by triple- and standard-strength four-dose hepatitis B vaccination regimens in hemodialysis patients: A multicenter, randomized, parallel-controlled trial in Six cities in Shanxi Province.
Yao T, Li Y, Zhang Y, Sun Y, Guo Y, Wang J, Song X, Zhang W, Wei B, Bai J, Wang H, Yu W, Wang H, Jiao L, Diao Y, Liu L, Shi S, Yang J, Ren X, Liu W, Fang J, Wang S, Liang X, Feng Y. Yao T, et al. Among authors: wang h, wang j, wang s. J Infect Dis. 2024 Oct 8:jiae494. doi: 10.1093/infdis/jiae494. Online ahead of print. J Infect Dis. 2024. PMID: 39378326
Evaluation of safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate in management of hyperkalaemia in China: a real-world study protocol.
Shen N, Meng Q, Zhang L, Xie H, Zhao J, Xing C, Zuo L, Long G, Zhu Q, Shan C, Cai X, Yang J, Luo X, Wang J, Ye J, Wan X, Tian S, Wu Y, Lin Y, Yu X, Li Q, Liu X, Shi Z, Zhou J, Liu C, Cao Y, Wang N, Jiang X, Wu H, Hu Y, Li L, Wang Z, He J, Cao J, Wu F, Ma C, Yin X, Li Z, Wang H, Lin H. Shen N, et al. Among authors: wang h, wang j, wang z, wang n. BMJ Open. 2023 Mar 8;13(3):e070530. doi: 10.1136/bmjopen-2022-070530. BMJ Open. 2023. PMID: 36889826 Free PMC article.
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study).
Shen N, Zhang L, Yang J, Lin Y, Liu X, Cai X, Cao J, Zhu Q, Luo X, Wan X, Wu H, Ye J, Shan C, Xie H, Wu Y, Cao Y, Wang J, Yu X, Wang H, He J, Tian S, Wu F, Jiang X, Li L, Zuo L, Wang Z, Xing C, Yin X, Zhao J, Ma C, Long G, Li Q, Hu Y, Shi Y, Lin H. Shen N, et al. Among authors: wang h, wang j, wang z. Front Pharmacol. 2024 Jul 29;15:1398953. doi: 10.3389/fphar.2024.1398953. eCollection 2024. Front Pharmacol. 2024. PMID: 39135788 Free PMC article.
215,538 results
You have reached the last available page of results. Please see the User Guide for more information.